Novartis Could Pay for Alleged Zometa Dangers
By ROSE BOUBOUSHIAN (CN) - Novartis may owe punitive damages to Pennsylvanians who developed jaw bone disease after taking Zometa, a drug meant to prevent bone problems among cancer…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
By ROSE BOUBOUSHIAN (CN) - Novartis may owe punitive damages to Pennsylvanians who developed jaw bone disease after taking Zometa, a drug meant to prevent bone problems among cancer…
You must be logged in to post a comment.